Rolland Gyulai

Title: Rolland Gyulai: Innovator in T Regulatory Cell Research

Introduction

Rolland Gyulai is a notable inventor based in Szeged, Hungary. He has made significant contributions to the field of immunology, particularly in the identification and treatment of T regulatory (Treg) cells. His innovative work has the potential to impact therapeutic strategies for various immune-related conditions.

Latest Patents

Gyulai holds a patent for "Methods and reagents for identifying/isolating T regulatory (Treg) cells and for treating individuals." This patent describes an affinity ligand that is reactive to the GARP protein, which can bind to an extracellular domain of the GARP protein expressed on Treg cells. The method involves providing a blood sample from a subject and determining the amount of Treg cells present. Additionally, the patent outlines the administration of a composition containing Treg cells to suppress effector T cell activity, as well as a composition containing an affinity ligand to increase effector T cell activity.

Career Highlights

Gyulai is affiliated with Case Western Reserve University, where he continues to advance research in immunology. His work has garnered attention for its innovative approach to manipulating Treg cell activity, which is crucial for developing new treatments for autoimmune diseases and other immune disorders.

Collaborations

Gyulai has collaborated with esteemed colleagues, including Hideaki Sugiyama and Thomas S McCormick. These partnerships have further enriched his research and contributed to the advancement of knowledge in the field.

Conclusion

Rolland Gyulai's contributions to the understanding and manipulation of T regulatory cells represent a significant advancement in immunology. His innovative patent and ongoing research efforts hold promise for future therapeutic applications.